PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
LegalView

Press Release


Receive press releases from LegalView: By Email RSS Feeds:

LegalView.info Announces Avandia Information Portal Update


LegalView.info, a leader in online personal legal information, is pleased to announce an upcoming addition to their Avandia portal.

Denver, CO, March 22, 2010 --(PR.com)-- LegalView.info, an online leader in personal injury legal assistance, is pleased to announce its newest content addition soon to appear on the recently restored Avandia information portal, available at http://avandia.legalview.com/ . Since the inception of the Avandia site, visitors have been given access to a wealth of information concerning the prescription drug used for managing diabetes. Articles, press releases, web links and an opportunity to connect with an Avandia attorney for free have drawn massive amounts of traffic to the Avandia page.

The latest release from the LegalView.info press release team covers a recent decision by the the U.S. Senate Committee on Finance which seems to be particularly damning to the pharmaceutical giant GlaxoSmithKline (GSK) and its diabetes drug, Avandia. As many are already aware, Avandia has been involved in some controversy regarding alleged dangerous side effects involving cardiac complications. In a letter attached to the Committee's report, two Senators explicitly state that, "The totality of evidence suggests that GlaxoSmithKline was aware of the possible cardiac risks associated with Avandia years before such evidence became public."

In a promptly written response, GSK decried the findings of the Senate Finance Committee, stating that the report, "...draws conclusions on the safety of Avandia (rosiglitazone) that are based on analysis that are not consistent with the rigorous scientific evidence supporting the safety of the drug."

The sales of the medication have dropped off significantly from its peak year; in 2006, Avandia garnered $2.6 billion in world sales. In 2009, it earned GSK only $721 million. The alleged risk of serious Avandia side effects has both doctors and patients shying away from the medication.

In addition to its extensive Avandia resources, LegalView.info also provides users with other personal injury resource portals. One such access site is its expansive mesothelioma page. There, individuals can find access to a wealth of legal information regarding mesothelioma, including access to mesothelioma litigation and experienced mesothelioma lawyers.

LegalView.info is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation’s most highly respected law firms: Anapol Schwartz; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.info’s superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.Legalview.info.

###
Contact Information
LegalView
Danielle Franklin
720-226-6613
Contact
http://avandia.legalview.com

Click here to view the list of recent Press Releases from LegalView
Promote Your Business